<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Inherited <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> contribute importantly to adverse cardiovascular outcomes and affect <z:hpo ids='HP_0000001'>all</z:hpo> tissue types </plain></SENT>
<SENT sid="1" pm="."><plain>This review summarizes some of the more important aspects </plain></SENT>
<SENT sid="2" pm="."><plain>In the venous system, heterozygosities for the factor V Leiden and prothrombin 20210G &gt; A mutations are common and occur in 4% and 1%, respectively, of caucasians </plain></SENT>
<SENT sid="3" pm="."><plain>They confer a 2- to 3- fold increase in risk of venous, but not arterial, <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> affects the systemic circulation and has a population prevalence of about 1 in 4000 </plain></SENT>
<SENT sid="5" pm="."><plain>The more than 200 mutations responsible are in the fibrillin-1 gene (15q21.1) and mediate the characteristic skeletal, lens and aortic changes </plain></SENT>
<SENT sid="6" pm="."><plain>There are two potentially lethal inherited disorders of cardiac conduction, the long QT and <z:e sem="disease" ids="C1142166" disease_type="Disease or Syndrome" abbrv="SUNDS">Brugada syndromes</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The prevalence for each is about 1 in 10,000 </plain></SENT>
<SENT sid="8" pm="."><plain>On the other hand, <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathies</z:hpo> are relatively common, at 1 in 500, but with variable penetrance </plain></SENT>
<SENT sid="9" pm="."><plain>Mutations are in the sarcomere proteins and more than 140 are known </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0001639'>Hypertrophic cardiomyopathy</z:hpo> may be confused with <z:e sem="disease" ids="C0002986" disease_type="Disease or Syndrome" abbrv="">Fabry disease</z:e>, for which effective treatment is now available </plain></SENT>
<SENT sid="11" pm="."><plain>Mutations in several genes have been shown to produce <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> in the young, but there is as yet no specific treatment </plain></SENT>
<SENT sid="12" pm="."><plain>In fatty acid oxidation disorders, <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> and <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> occur during <z:hpo ids='HP_0011009'>acute</z:hpo> decompensation </plain></SENT>
<SENT sid="13" pm="."><plain>An important recently established cause of <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> is <z:chebi fb="1" ids="16347,3424">carnitine</z:chebi> transporter defect; it is treated effectively with oral <z:chebi fb="1" ids="16347,3424">carnitine</z:chebi> </plain></SENT>
<SENT sid="14" pm="."><plain>The <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> arrhythmogenic right ventricular <z:mpath ids='MPATH_589'>dysplasia</z:mpath> occurs with a prevalence of about 1 in 15,000 and presents with arrythmias and a <z:mp ids='MP_0002754'>dilated right ventricle</z:mp> </plain></SENT>
<SENT sid="15" pm="."><plain>The mutations responsible have been mapped to chromosomes 1, 2, 10 and 14 </plain></SENT>
<SENT sid="16" pm="."><plain><z:e sem="disease" ids="C0085078" disease_type="Disease or Syndrome" abbrv="">Lysosomal storage disorders</z:e>, the <z:e sem="disease" ids="C0013720" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Ehlers-Danlos syndrome</z:e> and other <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective-tissue disorders</z:e> affect cardiac valves and vessels </plain></SENT>
<SENT sid="17" pm="."><plain>In addition to the relatively common inherited <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> disorders <z:e sem="disease" ids="C0020445" disease_type="Disease or Syndrome" abbrv="">familial hypercholesterolaemia</z:e> and <z:e sem="disease" ids="C0020474,C1704417" disease_type="Disease or Syndrome" abbrv="">familial combined hyperlipidaemia</z:e>, an important dominantly inherited <z:chebi fb="23" ids="18059">lipid</z:chebi> variable contributing to coronary risk is <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>(a) </plain></SENT>
<SENT sid="18" pm="."><plain>The gene is localized to chromosome 6 and there is full expression in childhood </plain></SENT>
<SENT sid="19" pm="."><plain>Elevated <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>(a) levels contribute to the occurrence and severity of early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:hpo ids='HP_0001677'>coronary disease</z:hpo> and add to the already enhanced risk in patients with <z:e sem="disease" ids="C0020445" disease_type="Disease or Syndrome" abbrv="">familial hypercholesterolaemia</z:e> </plain></SENT>
</text></document>